Home Treatment of Acute Pancreatitis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01796652|
Recruitment Status : Completed
First Posted : February 22, 2013
Last Update Posted : February 22, 2013
|Condition or disease|
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||84 participants|
|Target Follow-Up Duration:||30 Days|
|Official Title:||A Randomized Controlled Trial of Home Monitoring Versus Hospitalization in Mild Non-Alcoholic Acute Interstitial Pancreatitis|
|Study Start Date :||November 2011|
|Actual Primary Completion Date :||June 2012|
|Actual Study Completion Date :||June 2012|
Home and hospital treatment groups
Patients were randomized into either home or hospital groups after a brief hospitalization(≤24 hours. Hospital patients were followed 5 days in hospital.Home patients were visited on 2nd,3rd and 5th days by a staff nurse and the vital signs, symptoms, and general condition were recorded and transmitted back to the attending physician. On the 7th, 14th and 30th days, the home and hospital group patients were requested to return for a follow-up clinic visit at Bezmialem, at which time an assessment of their symptoms, physical examination, and laboratory evaluation was conducted.
- The primary outcome of the study was the 30 day hospital readmission rate. [ Time Frame: 30 days ]30 day hospital readmission of home and hospital groups of patients were evaluated.
- Other outcomes evaluated included the duration of abdominal pain and time to resumption of an oral diet, both measured in hours from the time of presentation. [ Time Frame: hours ]
Elaboration time of abdominal pain in home and hospital group patients as hour from the admission time to ICU.
Time to resumption of an oral diet measured from the time of presentation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01796652
|Bezmialem Vakıf University Hospital, Gastroenterology Clinic|
|İstanbul, Turkey, 34093|
|Principal Investigator:||Hakan Şentürk, Prof.||Bezmialem Vakıf University Hospital, Gastroenterology Clinic|